Skip Navigation

Faculty Directory

Clarence K. Lam, MD

Preventive Medicine

Contact Information

615 N. Wolfe St. WB602
Baltimore , Maryland   21205


MD , University of Maryland School of Medicine
MPH , Johns Hopkins BSPH


Clarence Lam, M.D., M.P.H. currently serves as the chief resident in preventive medicine at the Johns Hopkins Bloomberg School of Public Health.  He is a Phi Beta Kappa graduate of Case Western Reserve University where he completed his Bachelor of Arts in political science and biology.  He earned his medical degree from the University of Maryland and his Master of Public Health from Johns Hopkins University. 

While in medical school, he was elected as the student-body president of the University of Maryland, Baltimore, and he served on the health affairs staff of the Committee on Oversight and Government Reform of the U.S. House of Representatives where he conducted oversight investigations on drug safety policy.  He also worked as an analyst at the Center for Biosecurity where he authored several publications on biodefense policy and public health preparedness.  During residency, he was a representative to his institution’s Graduate Medical Education Committee and Residency Advisory Committee.  He was also elected as the Vice President of Membership and Recruitment for the American College of Preventive Medicine’s Resident Physicians Section.  In the past, he served two AmeriCorps terms in health education and advocacy in Cleveland, Ohio. 

In addition to his responsibilities as chief resident, he currently serves as a consultant to the FDA on drug shortages, is on the legislative staff of the only physician in the Maryland General Assembly, and is a member of the Board of Directors of Healthy Howard, an award-winning program whose mission is to ensure that access to medical and preventive care is available to all residents in Howard County, Maryland. 

Honors and Awards

David Paton Scholarship in Preventive Medicine (2010), Robley Dunglison Award for Excellence in Preventive Medicine (2008), Phi Beta Kappa (2003)

Health policy, legislative policy, leadership and management, public health preparedness, biodefense policy, drug shortages, advocacy, media, political engagement

  • Chou R, Croswell JM, Dana T, Bougatsos C, Blazina I, Fu R, Gleitsmann K, Koenig HC, Lam C, Maltz A, Rugge JB, Lin K.  Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force.  Ann Intern Med. 2011 Oct 7.

  • Lin KW, Lam C.  Screening for obesity in children and adolescents.  Am Fam Physician 2011 Mar 15;83(6):737.

  • Lin KW, Lam C.  Screening for depression in adults.  Am Fam Physician 2010 Oct 15;82(8):985-6.

  • Maldin B, Lam C, Franco C, Press D, Waldhorn R, Toner E, O’Toole T, Inglesby TV. Regional Approaches to Hospital Preparedness. Biosecurity and Bioterrorism 2007;5(1):43-53.

  • Borio L, Lam C. “Bioterrorism Agents.” In Clinical Microbiology Made Ridiculously Simple, 4th edition; Gladwin M, Trattler B, Eds.; MedMaster: Miami, 2007.